Heerlen, NL, 10 Mar 2022 08:00 CET
Royal DSM, a global purpose-led science-based company, today announces the repurchase, starting 10 March 2022, of 1,330,000 ordinary shares: 600,000 ordinary shares to cover commitments under share-based compensation plans and 730,000 ordinary shares to cover commitments for stock dividend as part of the final dividend 2021. The share repurchase is equivalent to approximately €205 million based on the closing price of the DSM ordinary share on Euronext Amsterdam on 9 March 2022.
The share buyback will be executed within the limitations of the authority granted to the Managing Board by the Annual General Meeting (AGM). The total number of ordinary shares to be repurchased under this program represents approximately 0.8% of ordinary shares issued.
DSM has signed a Discretionary Management Agreement with a bank to commence the execution of the share repurchase program on its behalf and to make trading decisions under the Agreement independently of DSM.
In accordance with regulations DSM will inform the market about the progress made in the execution of this program through weekly press releases. The share repurchase program is anticipated to be completed in Q2 2022.
DSM Media Relations
+31 (0) 45 5782420
Vice-President Investor Relations
+31 45 578 2864